Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer

Fig. 1

Representative pictures by immunochemistry for Class III β-tubulin, Sox2, and Survivin in 110 SOEC patients. Magnification 400×. Class III β-tubulin expression: (a) negative expression in serous carcinoma, (b) low expression in serous carcinoma, (c) high expression in clear carcinoma. Sox2 expression: (d) negative expression in serous carcinoma, (e) low expression in serous carcinoma, (f) high expression in mucous carcinoma. Survivin expression: (g) only nuclear expression in serous carcinoma, (h) only cytoplasmic expression in serous carcinoma, (i) both nuclear and cytoplasmic expression in serous carcinoma

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us